Folic acid supplementation improves vascular function in amenorrheic runners

Clinical Journal of Sport Medicine

Volumn 20, Issue 3, 2010, Pages 205-210

  Hoch, Anne Z ^a,b   Lynch, Stacy L ^a   Jurva, Jason W ^b   Schimke, Jane E ^a   Gutterman, David D ^b  

^a Orthopaedic Surgery   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Amenorrhea; Female athlete; Flowmediated dilation; Folic acid; Runners

Indexed keywords

FOLIC ACID;

ADULT; AMENORRHEA; ARTICLE; BLOOD FLOWMETRY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW MEDIATED DILATION; FOLIC ACID BLOOD LEVEL; HUMAN; HYPEREMIA; PRIORITY JOURNAL; RUNNING; SUPPLEMENTATION; VASCULAR ENDOTHELIUM;

ACADEMIC MEDICAL CENTERS; ADULT; AMENORRHEA; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; DILATATION; FEMALE; FOLIC ACID; HUMANS; MIDWESTERN UNITED STATES; RUNNING; YOUNG ADULT;

EID: 77952002337     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/JSM.0b013e3181df59f4     Document Type: Article

References (49)

1. Ohmichi M, Kanda Y, Hisamoto K, et al. Rapid changes of flow-mediated dilatation after surgical menopause. Maturitas. 2003;44:125-131.
2. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936-941.
3. Walther C, Gielen S, Hambrecht R. The effect of exercise training on endothelial function in cardiovascular disease in humans. Exerc Sport Sci Rev. 2004;32:129-134.
4. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol. 1997;30:325-333.
5. Ganz P, Vita JA. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation. 2003;108:2049-2053.
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
7. Rickenlund A, Eriksson MJ, Schenck-Gustafsson K, et al. Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile. J Clin Endocrinol Metab. 2005;90:1354-1359.
8. Rickenlund A, Eriksson MJ, Schenck-Gustafsson K, et al. Oral contraceptives improve endothelial function in amenorrheic athletes. J Clin Endocrinol Metab. 2005;90:3162-3167.
9. Hoch AZ, Dempsey RL, Carrera GF, et al. Is there an association between athletic amenorrhea and endothelial cell dysfunction? Med Sci Sports Exerc. 2003;35:377-383.
10. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
11. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
12. Maxwell AJ, Anderson BE, Cooke JP. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Vasc Med. 2000;5:11-19.
13. Verhaar MC, Wever RM, Kastelein JJ, et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia: a randomized placebo-controlled trial. Circulation. 1999;100:335-338.
14. Wilmink HW, Stroes ES, Erkelens WD, et al. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2000;20:185-188.
15. Hoch AZ, Pajewski NM, Hoffmann RG, et al. Possible relationship of folic acid supplementation and improved flow-mediated dilation in premenopausal, eumenorrheic athletic women. J Sports Sci Med. 2009;8:123-129.
16. Hashimoto M, Akishita M, Eto M, et al. Modulation of endotheliumdependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 1995;92:3431-3435.
17. Mather KJ, Norman EG, Prior JC, et al. Preserved forearm endothelial responses with acute exposure to progesterone: a randomized cross-over trial of 17-beta estradiol, progesterone, and 17-beta estradiol with progesterone in healthy menopausal women. J Clin Endocrinol Metab. 2000;85:4644-4649.
18. Williams MR, Westerman RA, Kingwell BA, et al. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab. 2001;86:5389-5395.
19. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-265.
20. Doshi SN, Naka KK, Payne N, et al. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci (Lond). 2001;101:629-635.
21. Verhaar MC, Wever RM, Kastelein JJ, et al. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 1998;97:237-241.
22. van Dijk RA, Rauwerda JA, Steyn M, et al. Long-term homocysteinelowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol. 2001;21:2072-2079.
23. van Etten RW, de Koning EJ, Verhaar MC, et al. Impaired NO-dependent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia. 2002;45:1004-1010.
24. Doshi SN, McDowell IF, Moat SJ, et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol. 2001;21:1196-1202.
25. Doshi SN, McDowell IF, Moat SJ, et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 2002;105:22-26.
26. Heiss G, Wallace R, Anderson GL, et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008;299:1036-1045.
27. Schutte AE, Huisman HW, Oosthuizen W, et al. Cardiovascular effects of oral supplementation of vitamin C, E and folic acid in young healthy males. Int J Vitam Nutr Res. 2004;74:285-293.
28. Mangoni AA, Sherwood RA, Swift CG, et al. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med. 2002;252:497-503.
29. Chambers JC, Ueland PM, Obeid OA, et al. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 2000;102:2479-2483.
30. Mangoni AA, Sherwood RA, Asonganyi B, et al. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens. 2005;18:220-226.
31. Mangoni AA, Ouldred E, Swif CG, et al. Vascular and blood pressure effects of folic acid in older patients with cardiovascular disease. J Am Geriatr Soc. 2001;49:1003-1004.
32. Deol PS, Barnes TA, Dampier K, et al. The effects of folic acid supplements on coagulation status in pregnancy. Br J Haematol. 2004;127:204-208.
33. Undas A, Domagala TB, Jankowski M, et al. Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. Thromb Res. 1999;95:281-288.
34. Mangoni AA, Arya R, Ford E, et al. Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial. Thromb Res. 2003;110:13-17.
35. Wever RM, van Dam T, van Rijn HJ, et al. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun. 1997;237:340-344.
36. Pancharuniti N, Lewis CA, Sauberlich HE, et al. Plasma homocyst (e) ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr. 1994;59:940-948.
37. van den BM, Boers GH, Franken DG, et al. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest. 1995;25:176-181.
38. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168-175.
39. Moens AL, Claeys MJ, Wuyts FL, et al. Effect of folic acid on endothelial function following acute myocardial infarction. Am J Cardiol. 2007;99:476-481.
40. Title LM, Ur E, Giddens K, et al. Folic acid improves endothelial dysfunction in type 2 diabetes-an effect independent of homocysteinelowering. Vasc Med. 2006;11:101-109.
41. Title LM, Cummings PM, Giddens K, et al. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol. 2000;36:758-765.
42. Woo KS, Chook P, Chan LL, et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med. 2002;112:535-539.
43. Woo KS, Chook P, Lolin YI, et al. Folic acid improves arterial endothelial function in adults with hyperhomocysteinemia. J Am Coll Cardiol. 1999;34:2002-2006.
44. US Food and Drug Administration. The FDA Safety Information and Adverse Event Reporting Program: Medical Product Safety Information Web site. http://www.fda.gov/medwatch/SAFETY.htm. Accessed December 8, 2008.
45. Hathcock JN. Vitamins and minerals: efficacy and safety. Am J Clin Nutr. 1997;66:427-437.
46. Birnbacher R, Messerschmidt AM, Pollak AP. Diagnosis and prevention of neural tube defects. Curr Opin Urol. 2002;12:461-464.
47. Herbert V. Folic acid. In: Shils M, Olson J, Shike M, et al, eds. Modern Nutrition in Health and Disease. Baltimore: Williams & Wilkins; 1999:433-466.
48. National Institutes of Health. National Institutes of Health, Office of Dietary Supplements. Dietary Supplement Fact Sheet: Folate. 2005. http://ods.od.nih.gov/factsheets/folate.asp#en10. Accessed November 13, 2008.
49. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297:2351-2359.